Literature DB >> 23850180

Significant association between angiotensin-converting enzyme gene insertion/deletion polymorphism and risk of recurrent miscarriage: a systematic review and meta-analysis.

Zengfang Wang1, Pingping Wang, Ximei Wang, Xiaoqin He, Zengyan Wang, Donghua Xu, Jiying Hu, Bin Wang.   

Abstract

BACKGROUND: Many studies have investigated the association between angiotensin-converting enzyme (ACE) gene insertion/deletion (I/D) polymorphism and risk of recurrent miscarriage, but the impact is unclear due to inconsistencies among those studies. This study aimed to quantify the strength of the association between ACE I/D polymorphism and recurrent miscarriage risk by performing a systematic review and meta-analysis. DESIGN AND METHODS: We searched PubMed, Embase, Web of Science, and Wanfang Medicine databases for eligible articles relating the association between ACE I/D polymorphism and risk of recurrent miscarriage in humans. We estimated the summary odds ratios (ORs) with their 95% confidence intervals (95% CIs) to assess the association.
RESULTS: Eleven studies with a total of 3357 individuals were included in this meta-analysis. Compared to the ACE II genotype, DD and ID were both associated with increased risk of recurrent miscarriage (OR DD versus II=1.81, 95% CI 1.23-2.66, P=0.003; OR ID versus II=1.50, 95% CI 1.25-1.80, P<0.001). Sensitivity analyses further confirmed the association above. No evidence of publication bias was observed.
CONCLUSION: Meta-analyses of available data show a significant association between ACE I/D polymorphism and recurrent miscarriage risk, and the ACE polymorphic D allele contributes to increased risk of recurrent miscarriage.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  95% CI; 95% confidence interval; ACE; ACE I/D; Angiotensin-converting enzyme; Gene polymorphism; HWE; Hardy–Weinberg equilibrium; Meta-analysis; OR; Recurrent miscarriage; odds ratio; skewed X chromosome inactivation.; skewed XCI

Mesh:

Substances:

Year:  2013        PMID: 23850180     DOI: 10.1016/j.metabol.2013.03.003

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  7 in total

Review 1.  The Angiotensin-converting Enzyme Insertion/Deletion Polymorphism as a Common Risk Factor for Major Pregnancy Complications.

Authors:  Christos Yapijakis; Iphigenia Gintoni; Maria Adamopoulou
Journal:  In Vivo       Date:  2021 Jan-Feb       Impact factor: 2.155

2.  A novel rodent model of pregnancy complications associated with genetically determined angiotensin-converting enzyme (ACE) activity.

Authors:  Eugenia Mata-Greenwood; Arlin B Blood; LeeAnna D Sands; Shannon L Bragg; Daliao Xiao; Lubo Zhang
Journal:  Am J Physiol Endocrinol Metab       Date:  2018-01-23       Impact factor: 4.310

Review 3.  Genetic considerations in recurrent pregnancy loss.

Authors:  Kassie J Hyde; Danny J Schust
Journal:  Cold Spring Harb Perspect Med       Date:  2015-02-06       Impact factor: 6.915

4.  The interaction effect of angiogenesis and endothelial dysfunction-related gene variants increases the susceptibility of recurrent pregnancy loss.

Authors:  E A Trifonova; M G Swarovskaya; O A Ganzha; O V Voronkova; T V Gabidulina; V A Stepanov
Journal:  J Assist Reprod Genet       Date:  2019-01-24       Impact factor: 3.412

5.  A rare case of juvenile hypertension: coexistence of type 2 multiple endocrine neoplasia -related bilateral pheochromocytoma and reninoma in a young patient with ACE gene polymorphism.

Authors:  Rosa Maria Paragliola; Ettore Capoluongo; Francesco Torino; Angelo Minucci; Giulia Canu; Alessandro Prete; Alfredo Pontecorvi; Salvatore Maria Corsello
Journal:  BMC Endocr Disord       Date:  2015-06-18       Impact factor: 2.763

6.  Distribution of ACE insertion/deletion (I/D) polymorphism in Iranian populations.

Authors:  Mostafa Saadat
Journal:  Mol Biol Res Commun       Date:  2015-06

7.  Lack of Association between Angiotensin Converting Enzyme I/D Polymorphism and Unexplained Recurrent Miscarriage in Saudi Arabia.

Authors:  Fatimah Basil Al-Mukaynizi; Afrah AlKhuriji; Zaineb Babay; Mohammad Addar; Sooad AlDaihan; Mohammad Alanazi; Arjumand S Warsy
Journal:  J Med Biochem       Date:  2016-05-09       Impact factor: 3.402

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.